| ADT | Androgen Deprivation Therapy |
| AR | Androgen Receptor |
| AR-V7 | Androgen Receptor splice Variant 7 |
| CRPC | Castration-Resistant Prostate Cancer |
| mCRPC | metastatic Castration-Resistant Prostate Cancer |
| mHSPC | metastatic Hormone-Sensitive Prostate Cancer |
| NCCN | National Comprehensive Cancer Network |
| EAU | European Association of Urology |
| ISUP | International Society of Urological Pathology |
| NEPC | Neuroendocrine Prostate Cancer |
| PARP | Poly(ADP-ribose) Polymerase |
| PRC2 | Polycomb Repressive Complex 2 |
| PROTAC | Proteolysis-Targeting Chimera |
| PSA | Prostate-Specific Antigen |
| PSMA | Prostate-Specific Membrane Antigen |
| PET | Positron Emission Tomography |
| HRR | homologous recombination repair |
| DLL3 | Delta-Like Ligand 3 |